Neoantigen landscape dynamics during human melanoma–T cell interactions-Reference-Cited by-同舟云学术

Neoantigen landscape dynamics during human melanoma–T cell interactions

Published:2016-06-27 Issue:7614 Volume:536 Page:91-95
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Verdegaal Els M. E.,de Miranda Noel F. C. C.,Visser Marten,Harryvan Tom,van Buuren Marit M.,Andersen Rikke S.,Hadrup Sine R.,van der Minne Caroline E.,Schotte Remko,Spits Hergen,Haanen John B. A. G.,Kapiteijn Ellen H. W.,Schumacher Ton N.,van der Burg Sjoerd H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/nature18945.pdf

Reference29 articles.

1. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577–581 (2014)

2. Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509–2520 (2015)

3. Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81–85 (2015)

4. Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015)

5. Robbins, P. F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747–752 (2013)

Cited by 381 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered epitopes enhance macrophage‐mediated anti‐tumour immunity to low‐immunogenic tumour mutations;Immunology;2024-08-22

2. Interferon-γ driven differentiation of monocytes into PD-L1⁺and MHC II⁺macrophages and the frequency of Tim-3⁺tumor-reactive CD8⁺T cells within the tumor microenvironment predict a positive response to anti-PD-1-based therapy in tumor-bearing mice;2024-08-04

3. RNA vaccines for cancer: Principles to practice;Cancer Cell;2024-07

4. Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer;Antibodies;2024-06-10

5. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05